Skip to main content
. 2022 Sep 7;38(9):373–381. doi: 10.1007/s40267-022-00937-3

Fig. 1.

Fig. 1

Immunogenicity of RTS,S/AS01 in children receiving three priming doses and annual booster doses in a phase 3 seasonal malaria vaccination trial [17]